In addition, TLR4 can mediate hyperglycemia, insulin resistance and proinflammatory molecule production, decreasing ApoM gene expression and plasma ApoM, damage gut-vascular barrier (GVB), thereby aggravate the intestinal function27. This evidence concerns the gene APOM and Hyperglycemia.